SouthState Corp’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.47K Sell
35
-10
-22% -$540 ﹤0.01% 910
2026
Q1
$2.35K Sell
45
-15
-25% -$900 ﹤0.01% 871
2025
Q4
$3.53K Buy
60
+5
+9% +$304 ﹤0.01% 869
2025
Q3
$3.06K Sell
55
-45
-45% -$2.41K ﹤0.01% 854
2025
Q2
$5.14K Buy
100
+43
+75% +$2.16K ﹤0.01% 907
2025
Q1
$3.34K Buy
+57
New +$3.86K ﹤0.01% 1067
2024
Q2
Sell
-636
Closed -$44.8K 756
2024
Q1
$44.8K Buy
+636
New +$45.5K ﹤0.01% 383

Other funds holding TECH

SouthState Corp's TECH Position: Q2 2026 in Review

SouthState Corp reduced its Bio-Techne (TECH) stake by 22% in Q2 2026, selling an estimated $540 and leaving 35 shares worth $2.47K. The position accounts for ﹤0.01% of the portfolio, ranked #910.

SouthState Corp first reported a position in TECH in Q1 2024 and has held it in 7 quarters since. The position peaked at $44.8K in Q1 2024. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • SouthState Corp held 35 shares of Bio-Techne worth $2.47K as of Q2 2026.
  • SouthState Corp sold 10 Bio-Techne shares in Q2 2026, an estimated $540.
  • Bio-Techne made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #910 holding.
  • SouthState Corp first reported a position in Bio-Techne in Q1 2024 and has held it in 7 quarters since.
  • SouthState Corp's Bio-Techne position peaked at $44.8K in Q1 2024.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.